Lista de obras - Agnieszka Pałucha-Poniewiera

A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action

artículo científico publicado en 2015

A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats

artículo científico publicado en 2012

Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc

artículo científico publicado en 2015

Activation of the mGlu7 receptor elicits antidepressant-like effects in mice

artículo científico publicado en 2007

Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats

artículo científico publicado en 2014

Antidepressant-like activity of 8-Br-cAMP, a PKA activator, in the forced swim test

artículo científico publicado en 2008

Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats

artículo científico publicado en 2003

Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.

artículo científico publicado en 2016

Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.

artículo científico publicado en 2005

Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.

artículo científico publicado en 2002

Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor

artículo científico publicado en 2012

Are compounds acting at metabotropic glutamate receptors the answer to treating depression?

artículo científico publicado en 2006

Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity.

artículo científico publicado en 2007

Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex

artículo científico publicado en 2007

Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus.

artículo científico publicado en 2002

Glutamate-Based Drug Discovery for Novel Antidepressants

artículo científico publicado en 2016

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

artículo científico publicado en 2016

Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice

artículo científico publicado en 2009

Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats.

artículo científico publicado en 2004

In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling

artículo científico publicado en 2004

Interaction of zinc with antidepressants in the forced swimming test in mice

artículo científico publicado en 2002

Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping

artículo científico publicado en 2001

Investigational NMDA receptor modulators for depression ⬇️

artículo científico publicado el 21 de noviembre de 2011

Involvement of CRF but not NPY in the anxiety regulation via NMDA receptors

artículo científico publicado en 2003

Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test

artículo científico publicado en 2012

Is the mGlu5 receptor a possible target for new antidepressant drugs?

artículo científico

Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems

artículo científico publicado en 2010

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

artículo científico publicado en 2007

NMDA antagonists under investigation for the treatment of major depressive disorder

artículo científico publicado en 2014

Negative Allosteric Modulators of mGlu Receptor as Putative Antipsychotic Drugs

artículo científico publicado en 2018

On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice

artículo científico publicado en 2011

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.

artículo científico publicado en 2010

On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants

artículo científico publicado en 2002

Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents

artículo científico publicado en 2008

Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist

artículo científico publicado en 2005

Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors

artículo científico publicado en 2014

Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats

scientific article published on 01 September 2019

Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.

artículo científico publicado en 2004

The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent

artículo científico publicado en 2014

The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent

artículo científico publicado en 2010

The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice

artículo científico publicado en 2021

The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.

artículo científico publicado en 2009

The influence of the duration of chronic unpredictable mild stress on the behavioural responses of C57BL/6J mice

scientific article published on 18 May 2020

The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test

artículo científico publicado en 2017

The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice

scientific article published on 23 August 2018

The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug

scientific article published on 09 February 2018

Lista de obras de Agnieszka Pałucha-Poniewiera

A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action

A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats

Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc

Activation of the mGlu7 receptor elicits antidepressant-like effects in mice

Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats

Antidepressant-like activity of 8-Br-cAMP, a PKA activator, in the forced swim test

Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats

Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.

Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.

Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.

Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor

Are compounds acting at metabotropic glutamate receptors the answer to treating depression?

Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity.

Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex

Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus.

Glutamate-Based Drug Discovery for Novel Antidepressants

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats

Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice

Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats.

In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling

Interaction of zinc with antidepressants in the forced swimming test in mice

Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping

Investigational NMDA receptor modulators for depression ⬇️

Involvement of CRF but not NPY in the anxiety regulation via NMDA receptors

Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test

Is the mGlu5 receptor a possible target for new antidepressant drugs?

Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

NMDA antagonists under investigation for the treatment of major depressive disorder

Negative Allosteric Modulators of mGlu Receptor as Putative Antipsychotic Drugs

On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.

On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants

Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents

Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist

Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors

Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats

Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.

The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent

The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent

The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice

The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.

The influence of the duration of chronic unpredictable mild stress on the behavioural responses of C57BL/6J mice

The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test

The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice

The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug